Identity
- Trade Name
- Thoraguard FDA UDI
- Generic Name
- Thoracic suction pump FDA UDI
- Device Name
- Thoraguard Control Module FDA UDI
- Model / Reference
- FGN-1387 FDA UDI
- Description
- Thoraguard Control Module FDA UDI
Identifiers
- Catalog Number
- TGCM1000 FDA UDI
- Primary DI / UDI-DI
- 00860000436427 FDA UDI
- 510(k) Number
- K181667 FDA UDI
- FDA Product Code
- BTA FDA UDI
- GMDN Term
- Thoracic suction pump FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 878.4780 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Unsafe FDA UDI
Category: Thoracic suction pump
Thoraguard by Centese, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Thoracic suction pump.
- Passio Handheld Control Unit — BEARPAC MEDICAL, LLC · Class II
- Thopaz+ — Medela LLC · Class II
- ATMOS — ATMOS MedizinTechnik GmbH & Co. KG · Class II
- Thopaz+ — Medela LLC · Class II
- ATMOS — ATMOS MedizinTechnik GmbH & Co. KG · Class II
- Thopaz+ — Medela LLC · Class II
- Passio Pump Drainage System — BEARPAC MEDICAL, LLC · Class II
Cleared under the same submission
K181667 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Centese, Inc.
Sources (1)
- FDA UDI 5ab5e631-8ba4-4cf5-8866-47800eaf15ae 36 fields · synced Jun 8, 2026